Interview season begins soon, which means it’s time to worry about the weird questions you’ll be asked during med school interviews. Kayla joined our new Facebook Group, The Short Coat Student Lounge, and asked what strange or difficult questions Lisa Wehr, Liza Mann, Irisa Mahaparn, and new co-host Mackenzie Walhof had been asked when it was their turn. Kayla’s question, of course, inspires Dave to have them try to play a game of Questions, at which all the co-hosts fail miserably.
This Week in Medical News
The FDA announced that it’s seeking public comment on plans to reduce nicotine in cigarettes to sub-addictive levels. Interesting idea…but we have questions. Google is trying to give US mobile users who search for info about depression a link to a screening tool for the disease…but we have questions. One thing we don’t question: our old friend Martin Shkreli’s securities fraud trial jury selection transcripts were released, and let’s just say the jury of his peers don’t give a rat’s butt about what he’s actually on trial for…they hate him for the drug thing.
Dave, John Pienta, Mark Moubarek, Matt Maves, and Levi Endelman are aware that the world is full of questions. Nowhere is that more true than on the saddest place on the Internet, Yahoo! Answers. There folks ask the kinds of things that a primary care physician might have to answer. Is removing a layer of skin with a razor a good way to get rid of acne scars? What could be the cause of blisters on one’s lips after kissing one’s dog? How much milk should one use in one’s bath? There are no stupid questions.
But first, since Matt has returned from a year in Des Moines doing clerkships there, we discuss what that’s been like and the benefits of doing some clerkships outside a more academic setting. We also discuss the psychiatric disorder pica and the kinds of things people swallow on purpose (or by accident). Also we talk about drug maker Mylan’s difficulties with, well, everyone after we collectively realized they’re gouging patients who need epinephrine auto-injectors to keep themselves alive. Meanwhile, a company is offering a supplement that its CEO, a pioneering MIT aging researcher, and it’s Nobel-prize festooned board of scientific advisors say might just be a way to extend the human health span.